You can align purpose and profit through a model where your marketplace success fuels meaningful mission—and that mission, in turn, strengthens the value of your marketplace success. Together they create lasting solutions and you become part of a sustainable cycle that expand hope, improve wellness, and sustain long-term impact. This is the Buy One, Nourish One model that we call Social Business 3.0.
You can champion solution-oriented products built on scientific development, intentional formulation, and research-driven innovation. Proprietary technologies and exclusive distribution relationships provide you with products designed to support meaningful physiological outcomes while creating value that extends beyond your own wellness to a larger social mission.
Through Social Business 3.0, your everyday purchases become something bigger than a transaction—they become a source of hope. Every purchase you make helps extend nutrition and support to vulnerable children around the world, allowing the products you choose for yourself to create meaningful impact in the life of someone else. You become part of something we call the Hope Movement.
51 Examples That Reveal What Scientists Discovered About Acemannan When Sam Caster first met these scientists in 1994, he said they were genuinely excited about Acemannan. Now I’d heard Sam tell that story before, and Read more
Part 3 of 4 The Patent Examiner Who Questioned Acemannan – and Evenutally Wanted In Audio Addendum: U.S. Patent Primary Area of Focus What It Provided Patent Support For Primary Examiner Assistant Examiner 5,587,364 Inflammatory Read more
Part 2 of 4 Inside U.S. Patent 5,308,838 and Its Extraordinary Range of Uses Expanding the Scientific Investigation After Patent 5,106,616 was issued, the same three inventors received another United States patent. Bill H. McAnalley. Read more
Part 1 of 4 Exploring U.S. Patent 5,106,616 – Administration of Acemannan An Entire Research Program Inside a Single Patent This video begins our exploration of two significant United States patents—both centered on Acemannan. Now, Read more
Why can’t it be just customers, with a simple commission payout, rather than a multi-level compensation structure? That’s a fair question, particularly when so much emphasis is placed on customers and genuine product demand. It Read more
When we think about the quality of a health care system, it is tempting to begin with the sophistication of its hospitals, the expertise of its physicians, or the extraordinary medical technologies now available. And Read more
Tony McWilliams
469-955-2001
Or contact the person who told you about this site